Immunomodulatory nanosystems

X Feng, W Xu, Z Li, W Song, J Ding… - Advanced science, 2019 - Wiley Online Library
Immunotherapy has emerged as an effective strategy for the prevention and treatment of a
variety of diseases, including cancer, infectious diseases, inflammatory diseases, and …

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment

AP Robinson, CT Harp, A Noronha, SD Miller - Handbook of clinical …, 2014 - Elsevier
While no single model can exactly recapitulate all aspects of multiple sclerosis (MS), animal
models are essential in understanding the induction and pathogenesis of the disease and to …

Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance

RA Maldonado, RA LaMothe… - Proceedings of the …, 2015 - National Acad Sciences
Current treatments to control pathological or unwanted immune responses often use broadly
immunosuppressive drugs. New approaches to induce antigen-specific immunological …

Antigen-specific therapeutic approaches for autoimmunity

P Serra, P Santamaria - Nature biotechnology, 2019 - nature.com
The main function of the immune system in health is to protect the host from infection by
microbes and parasites. Because immune responses to nonself bear the risk of unleashing …

Therapeutic induction of antigen-specific immune tolerance

JE Kenison, NA Stevens, FJ Quintana - Nature Reviews Immunology, 2024 - nature.com
The development of therapeutic approaches for the induction of robust, long-lasting and
antigen-specific immune tolerance remains an important unmet clinical need for the …

The role of the PD‐1 pathway in autoimmunity and peripheral tolerance

BT Fife, KE Pauken - Annals of the New York Academy of …, 2011 - Wiley Online Library
Programmed death‐1 (PD‐1) is a surface receptor critical for the regulation of T cell function
during immunity and tolerance. PD‐1 interactions with its ligands PD‐L1 and PD‐L2 inhibit T …

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.

MK Jenkins, RH Schwartz - The Journal of experimental medicine, 1987 - rupress.org
We investigated the antigen specificity and presentation requirements for inactivation of T
lymphocytes in vitro and in vivo. In vitro studies revealed that splenocytes treated with the …

The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets

R Hohlfeld, K Dornmair, E Meinl, H Wekerle - The Lancet Neurology, 2016 - thelancet.com
Identification of the target antigens of pathogenic antibodies and T cells is of fundamental
importance for understanding the pathogenesis of multiple sclerosis, and for the …

Antigen-specific tolerance by autologous myelin peptide–coupled cells: a phase 1 trial in multiple sclerosis

A Lutterotti, S Yousef, A Sputtek, KH Stürner… - Science translational …, 2013 - science.org
Multiple sclerosis (MS) is a devastating inflammatory disease of the brain and spinal cord
that is thought to result from an autoimmune attack directed against antigens in the central …

Harnessing nanoparticles for immune modulation

DR Getts, LD Shea, SD Miller, NJC King - Trends in immunology, 2015 - cell.com
Recent approaches using nanoparticles engineered for immune regulation have yielded
promising results in preclinical models of disease. The number of nanoparticle therapies is …